ArticleNature communications2025
Engineering wetware and software for the predictive design of compressed genetic circuits for higher-state decision-making.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Protecting cells at the genetic level and simulating unauthorized access via a biohackathon.Science advances · 2026Article
- Engineering wetware and software for the predictive design of compressed genetic circuits for higher-state decision-making.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Synthetic genetic circuits enable the reprogramming of cells, advancing the study and application of biology with greater precision. However, quantitative circuit design is hampered by the limited modularity of biological parts. As circuit complexity increases, this imposes a greater metabolic burden on chassis cells, which limits circuit design capacity. Here, we present a generalizable wetware and complementary software to enable the quantitative design of genetic circuits that utilize fewer parts for higher-state decision-making. We term the process of designing smaller genetic circuits as compression. To accomplish this, we develop scalable wetware that leverages sets of synthetic transcription factors (i.e., network capable repressors and anti-repressors) and synthetic promoters that facilitate the full development of 3-input Boolean logic compression circuits. Complementary software enables the design of higher-state circuits with a minimal genetic footprint and quantitatively precise performance setpoints. On average the resulting multi-state compression circuits are approximately 4-times smaller than canonical inverter-type genetic circuits. Our quantitative predictions have an average error below 1.4-fold for >50 test cases. Additionally, we successfully apply this technology toward the predictive design of a recombinase genetic memory circuit, and flux through a metabolic pathway with precise setpoints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.